Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 1/2006

01-03-2006

Challenges Identifying Genetic Determinants of Pediatric Cancers – the Childhood Leukemia Experience

Authors: Daniel Sinnett, Damian Labuda, Maja Krajinovic

Published in: Familial Cancer | Issue 1/2006

Login to get access
Metadata
Title
Challenges Identifying Genetic Determinants of Pediatric Cancers – the Childhood Leukemia Experience
Authors
Daniel Sinnett
Damian Labuda
Maja Krajinovic
Publication date
01-03-2006
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2006
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-005-2574-4

Other articles of this Issue 1/2006

Familial Cancer 1/2006 Go to the issue

OriginalPaper

The Value of Multi-Modal Gene Screening in HNPCC in Quebec: Three Mutations in Mismatch Repair Genes that would have not been Correctly Identified by Genomic DNA Sequencing Alone

OriginalPaper

Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis

OriginalPaper

The Challenge of Developing Evidence-Based Genetics Health Care in Practice

OriginalPaper

An Analysis of Unclassified Missense Substitutions in Human BRCA1

OriginalPaper

Oncogenetics and Interdisciplinary Collaborations: Essential for Progress

OriginalPaper

BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits